2023: Will The Road Ahead Be Any Smoother For The EU’s Medtech Regulations?
Executive Summary
Originally intended to increase medical device safety, the implementation of the EU’s medtech regulation was so hampered in 2022 that it had started to look as if the new regulations were a bigger potential threat to patients than any of the scandals leading to its more stringent requirements. With the European Commission’s latest plans to ease challenges around implementation, will 2023 be a more positive year for the EU medtech sector?
You may also be interested in...
Moves For Go Ahead For MDR Proposal To Be Discussed At European Parliament
The European Commission’s proposal to extend transition timelines for legacy devices in the context of the Medical Device Regulation is already on the move. There are still questions, however, about whether a fast-track adoption is in the best interests of the medtech sector.
Notified Bodies Follow Expert Panel Opinions Under EU MDR To The Letter
A review of expert panel opinions related to high-risk medical devices shows no challenges yet by notified bodies to their findings.
Commission Removes Warning Signs Relating To Four EU MDR Notified Bodies
There had been handful of warning signals against well-known notified bodies designated against the MDR. Why were they there and why have they just been removed?